Literature DB >> 6295944

Interferon production by leukocytes infiltrating the lungs of mice during primary influenza virus infection.

P R Wyde, M R Wilson, T R Cate.   

Abstract

Lung fluids and leukocytes were obtained from unprimed C3H mice by transpleural lavage at intervals after infection with influenza A/Hong Kong/68 virus and were tested for interferon activity. Lavage fluid interferon titers correlated directly with lung virus titers and with initial increases in leukocyte yields from infected lungs. In contrast to cultured lymph node cells from infected animals or leukocytes from lungs of uninfected mice, washed leukocytes obtained from the lungs of mice infected 2 to 6 days earlier produced interferon spontaneously in culture. The physiochemical, biological, and antigenic properties of both the interferon in lavage fluids and that produced by lung lavage leukocytes were similar and characteristics of alpha interferon. Fractionation studies indicated that macrophages and T lymphocytes were primarily responsible for the interferon produced in culture. The early presence and significant numbers of interferon-producing leukocytes in infected lungs suggests that these cells have an early role in defense against influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6295944      PMCID: PMC347882          DOI: 10.1128/iai.38.3.1249-1255.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Transfer of interferon-producing macrophages: new approach to viral chemotherapy.

Authors:  L A Glasgow
Journal:  Science       Date:  1970-11-20       Impact factor: 47.728

2.  Interferon and resistance to upper respiratory virus illness.

Authors:  T R Cate; R G Douglas; R B Couch
Journal:  Proc Soc Exp Biol Med       Date:  1969-06

3.  Production of interferon by alveolar macrophages.

Authors:  J D Acton; Q N Myrvik
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

4.  Fate of intravenously administered interferon and the distribution of interferon during virus infections in mice.

Authors:  T P Subrahmanyan; C A Mims
Journal:  Br J Exp Pathol       Date:  1966-04

5.  Depression of interferon production in mice after treatment with anti-lymphocyte serum.

Authors:  R F Barth; R A Malmgren; R M Friedman
Journal:  Lancet       Date:  1969-10-04       Impact factor: 79.321

6.  The influence of x-irradiation on survival and interferon levels in viral infected mice.

Authors:  A Hellman; D H Martin; L J Wopschall
Journal:  Proc Soc Exp Biol Med       Date:  1968-06

7.  Effects of cortisol and adrenalectomy on induction of interferon by endotoxin.

Authors:  B Postic; C DeAngelis; M K Breinig; M Ho
Journal:  Proc Soc Exp Biol Med       Date:  1967-05

8.  Inter- feron synthesis in x-irradiated animals. 3. The high radiosensitivity of myxovirus-induced circulating interferon production.

Authors:  E De Maeyer; J De Maeyer-Guignard; P Jullien
Journal:  Proc Soc Exp Biol Med       Date:  1969-05

9.  Two distinct populations of peripheral lymphocytes in mice distinguishable by immunofluorescence.

Authors:  M C Raff
Journal:  Immunology       Date:  1970-10       Impact factor: 7.397

10.  Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells.

Authors:  T J Smith; R R Wagner
Journal:  J Exp Med       Date:  1967-04-01       Impact factor: 14.307

View more
  10 in total

1.  The role of cell surface expression of influenza virus neuraminidase in induction of human lymphocyte apoptosis.

Authors:  Joan E Nichols; Jean A Niles; Elisa H Fleming; Norbert J Roberts
Journal:  Virology       Date:  2019-06-10       Impact factor: 3.616

2.  The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice.

Authors:  G E Price; A Gaszewska-Mastarlarz; D Moskophidis
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  GM-CSF in the lung protects against lethal influenza infection.

Authors:  Fang-Fang Huang; Peter F Barnes; Yan Feng; Ruben Donis; Zissis C Chroneos; Steven Idell; Timothy Allen; Daniel R Perez; Jeffrey A Whitsett; Kyri Dunussi-Joannopoulos; Homayoun Shams
Journal:  Am J Respir Crit Care Med       Date:  2011-04-07       Impact factor: 21.405

4.  Effect of environmental temperature on sleep, locomotor activity, core body temperature and immune responses of C57BL/6J mice.

Authors:  K A Jhaveri; R A Trammell; L A Toth
Journal:  Brain Behav Immun       Date:  2007-04-27       Impact factor: 7.217

5.  Pulmonary deposition and clearance of aerosolized interferon.

Authors:  P R Wyde; S Z Wilson; M J Kramer; C S Sun; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

6.  Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.

Authors:  I N Mbawuike; H R Six; T R Cate; R B Couch
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

7.  Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans.

Authors:  Jessica A Belser; Xuihua Lu; Taronna R Maines; Catherine Smith; Yan Li; Ruben O Donis; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

8.  Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity.

Authors:  Victor I Ayala; John R Teijaro; Donna L Farber; Susan G Dorsey; Nicholas H Carbonetti
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

9.  Influenza Virus Infection of Human Lymphocytes Occurs in the Immune Cell Cluster of the Developing Antiviral Response.

Authors:  David J Mock; Mark W Frampton; Joan E Nichols; Frank M Domurat; Denise J Signs; Norbert J Roberts
Journal:  Viruses       Date:  2018-08-10       Impact factor: 5.048

10.  HLA-associated protection of lymphocytes during influenza virus infection.

Authors:  Eliana E Ochoa; Ruksana Huda; Steven F Scheibel; Joan E Nichols; David J Mock; Nayef El-Daher; Frank M Domurat; Norbert J Roberts
Journal:  Virol J       Date:  2020-08-24       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.